Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: host-dependent differences in proteolytic cleavage and cell fusion

Cell fusion induced by infection with mouse hepatitis virus strain A59 (MHV-A59) varied markedly in extent and time course in four different murine cell lines. When inoculated at a multiplicity of 3 to 5 PFU per cell, the Sac-, L2, and DBT cell lines began to fuse by 7 h, were fused into confluent syncytia by 9 to 12 h, and peeled from the substrate by 10 to 14 h. These virulent virus-cell interactions were in striking contrast to the moderate interaction of MHV-A59 with the 17 Cl 1 cell line, in which only small syncytia were observed 18 h postinoculation, and greater than 50% of the cells remained unfused by 24 h. The yield of infectious virus produced by 17 Cl 1 cells was 10-fold higher than the yields from the other three cell lines. The processing of the nucleocapsid protein, the membrane glycoprotein E1, and the peplomeric glycoprotein E2 were found to differ significantly in the four cell lines. Since the E2 glycoprotein is responsible for virus-induced cell fusion, we attempted to correlate differences in cellular processing of E2 with differences in fusion of infected cells. The predominant intracellular form of E2 in all cell lines was the 180K species. Pulse-chase experiments showed that a small portion of the 17 Cl 1 cell-associated 180K E2 was cleaved by 1 h after synthesis to yield 90K E2, shown in the preceding paper to consist of two different glycoproteins called 90A and 90B (L. S. Sturman, C. S. Ricard, and K. V. Holmes, J. Virol. 56:904-911, 1985). This cleavage occurred shortly before the release of virions from cells, as shown by pulse-chase experiments. After budding at intracellular membranes, virions released into the medium by the four cell lines contained different ratios of 180K to 90K E2. Virions from Sac- cells, which contained 100% 90K E2, fused L2 cells rapidly without requiring virus replication, whereas virions from 17 Cl 1 cells, which had 50% 90K E2, required trypsin activation to induce rapid fusion (Sturman et al., J. Virol. 56:904-911, 1985). The addition of protease inhibitors to the medium markedly delayed L2 cell fusion induced by MHV infection. The extent of coronavirus-induced cell fusion does not depend solely upon the percent cleavage of the E2 glycoprotein by cellular proteases, since extensive fusion was induced by infection of L2 and DBT cells but not 17 Cl 1 cells, although all three cell lines cleaved E2 to the same extent.(ABSTRACT TRUNCATED AT 400 WORDS)

[1]  K. Holmes,et al.  Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: activation of cell-fusing activity of virions by trypsin and separation of two different 90K cleavage fragments , 1985, Journal of virology.

[2]  G. Appleyard,et al.  Inhibition of the growth of human coronavirus 229E by leupeptin. , 1985, The Journal of general virology.

[3]  S. Cheley,et al.  Fusion resistance and decreased infectability as major host cell determinants of coronavirus persistence , 1983, Virology.

[4]  A. Osterhaus,et al.  Temperature-sensitive mutants of mouse hepatitis virus strain A59: Isolation, characterization and neuropathogenic properties , 1983, Virology.

[5]  H. Klenk,et al.  Post-translational glycosylation of coronavirus glycoprotein E1: inhibition by monensin. , 1982, The EMBO journal.

[6]  D. Stern,et al.  Coronavirus proteins: biogenesis of avian infectious bronchitis virus virion proteins , 1982, Journal of virology.

[7]  R. Knobler,et al.  Monoclonal antibodies to murine hepatitis virus-4 (strain JHM) define the viral glycoprotein responsible for attachment and cell-cell fusion , 1982, Virology.

[8]  K. Holmes,et al.  Cell tropism and expression of mouse hepatitis viruses (MHV) in mouse spinal cord cultures☆ , 1982, Virology.

[9]  V. ter meulen,et al.  The structure and replication of coronaviruses. , 1982, Current Topics in Microbiology and Immunology.

[10]  V. ter meulen,et al.  The biology and pathogenesis of coronaviruses. , 1982, Current topics in microbiology and immunology.

[11]  H. Klenk,et al.  Coronavirus glycoprotein E1, a new type of viral glycoprotein☆ , 1981, Journal of Molecular Biology.

[12]  H. Klenk,et al.  Proteolytic activation of the influenza virus hemagglutinin: The structure of the cleavage site and the enzymes involved in cleavage. , 1981, Virology.

[13]  K. Holmes,et al.  Tunicamycin resistant glycosylation of a coronavirus glycoprotein: Demonstration of a novel type of viral glycoprotein , 1981, Virology.

[14]  V. Morris,et al.  RNA and polypeptide homology among murine coronaviruses , 1981, Virology.

[15]  J. Rothman,et al.  Early and late functions associated with the Golgi apparatus reside in distinct compartments. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[16]  H. Yoshikura,et al.  Role of protease in mouse hepatitis virus-induced cell fusion Studies with a cold-sensitive mutant isolated from a persistent infection , 1981, Virology.

[17]  K. Kawasaki,et al.  Interaction of influenza virus hemagglutinin with target membrane lipids is a key step in virus-induced hemolysis and fusion at pH 5.2. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Marian C. Horzinek,et al.  Translation of three mouse hepatitis virus strain A59 subgenomic RNAs in Xenopus laevis oocytes , 1981, Journal of virology.

[19]  D. Cavanagh Structural polypeptides of coronavirus IBV. , 1981, The Journal of general virology.

[20]  R. Rott,et al.  Enhancement of plaque formation and cell fusion of an enteropathogenic coronavirus by trypsin treatment , 1981, Infection and immunity.

[21]  V. ter meulen,et al.  Coronavirus JHM: intracellular protein synthesis. , 1981, The Journal of general virology.

[22]  Marian C. Horzinek,et al.  Isolation and identification of virus-specific mRNAs in cells infected with mouse hepatitis virus (MHV-A59) , 1981, Virology.

[23]  K. Holmes,et al.  Analysis of the functions of coronavirus glycoproteins by differential inhibition of synthesis with tunicamycin. , 1981, Advances in experimental medicine and biology.

[24]  F. Bang The use of a genetically incompatible combination of host and virus (MHV) for the study of mechanisms of host resistance. , 1981, Advances in experimental medicine and biology.

[25]  H. Klenk,et al.  Mutational changes of the protease susceptibility of glycoprotein F of Newcastle disease virus: effects on pathogenicity. , 1980, The Journal of general virology.

[26]  V. ter meulen,et al.  Coronavirus JHM: Cell-Free Synthesis of Structural Protein p60 , 1980, Journal of virology.

[27]  K. Holmes,et al.  Isolation of coronavirus envelope glycoproteins and interaction with the viral nucleocapsid , 1980, Journal of virology.

[28]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[29]  H. Klenk,et al.  The structure of the hemagglutinin, a determinant for the pathogenicity of influenza viruses. , 1979, Virology.

[30]  J. Robb,et al.  Pathogenic murine coronaviruses I. Characterization of biological behavior in vitro and virus-specific intracellular RNA of strongly neurotropic JHMV and weakly neurotropic A59V viruses , 1979, Virology.

[31]  W. Flintoff,et al.  In vivo and in vitro models of demyelinating diseases: Tropism of the JHM strain of murine hepatitis virus for cells of glial origin , 1977, Cell.

[32]  H. Klenk,et al.  Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of Newcastle disease virus. , 1976, Virology.

[33]  H Umezawa,et al.  Structures and activities of protease inhibitors of microbial origin. , 1976, Methods in enzymology.

[34]  A. Scheid,et al.  Protease activation mutants of sendai virus. Activation of biological properties by specific proteases. , 1976, Virology.

[35]  H. Klenk,et al.  Activation of influenza A viruses by trypsin treatment. , 1975, Virology.

[36]  P. Choppin,et al.  Enhancement of the infectivity of influenza A and B viruses by proteolytic cleavage of the hemagglutinin polypeptide. , 1975, Virology.

[37]  K. Mcintosh,et al.  Coronaviruses: a comparative review. , 1974 .

[38]  R. Compans,et al.  Proteolytic cleavage of the hemagglutinin polypeptide of influenza virus. Function of the uncleaved polypeptide HA. , 1973, Virology.

[39]  L. Sturman,et al.  Enhanced Growth of a Murine Coronavirus in Transformed Mouse Cells , 1972, Infection and immunity.

[40]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[41]  R. Chanock,et al.  Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease. , 1967, Proceedings of the National Academy of Sciences of the United States of America.

[42]  P. Choppin,et al.  ON THE ROLE OF THE RESPONSE OF THE CELL MEMBRANE IN DETERMINING VIRUS VIRULENCE , 1966, The Journal of experimental medicine.

[43]  J. Hartley,et al.  Tissue Culture Cytopathic and Plaque Assays for Mouse Hepatitis Viruses , 1963, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[44]  F. Bang,et al.  MOUSE MACROPHAGES AS HOST CELLS FOR THE MOUSE HEPATITIS VIRUS AND THE GENETIC BASIS OF THEIR SUSCEPTIBILITY. , 1960, Proceedings of the National Academy of Sciences of the United States of America.